Relevance of serum neurofilament light chain determination as a biomarker in multiple sclerosis. Consensus of the Spanish Society of Neurology's Study Group on Multiple Sclerosis and Related Neuroimmune Diseases J.M. García Domínguez; L. María Villar; G. Arrambide; Y. Blanco; M. Carmen Calles; B. Casanova; T. Castillo-Triviño; L. Costa-Frossard França; S. Eichau; M.Á. Hernández Pérez; L. Landete; J. Meca Lallana; C. Oreja-Guevara; J. María Prieto; L. Querol; A. Belén Caminero;

The prevalence, incidence, and clinical assessment of neuromyelitis optica spectrum disorder in patients with demyelinating diseases M.A. Mireles-Ramírez; I.E. Velázquez-Brizuela; N. Sánchez-Rosales; Y. Márquez-Pedroza; M.R. Hernandez-Preciado; G. Gabriel Ortiz;

Cognitive rehabilitation program in patients with multiple sclerosis: A pilot study R.M. Jiménez-Morales; Y. Broche-Pérez; Y. Macías-Delgado; C. Sebrango; S. Díaz-Díaz; R. Castiñeira-Rodriguez; F.J. Pérez-González; C. Forn;